Orphagen Pharmaceuticals
Pre-clinicalOrphagen Pharmaceuticals are leaders in the screening of ligands that modulate orphan nuclear receptors for the discovery of novel medicines
Founded
2001
Focus
Small Molecules
About
Orphagen Pharmaceuticals are leaders in the screening of ligands that modulate orphan nuclear receptors for the discovery of novel medicines
Funding History
4Total raised: $47M
Grant$2MNIHJun 15, 2015
Series C$20MUndisclosedJun 15, 2011
Series B$15MUndisclosedJun 15, 2007
Series A$10MUndisclosedJun 15, 2003
Company Info
TypePrivate
Founded2001
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile